Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

73.84
+1.181.62%
Post-market: 72.92-0.9200-1.25%18:15 EDT
Volume:146.73K
Turnover:10.48M
Market Cap:16.98M
PE:- -
High:74.25
Open:71.71
Low:67.19
Close:72.66
52wk High:143.84
52wk Low:14.95
Shares:230.00K
Float Shares:230.00K
Volume Ratio:0.54
T/O Rate:63.80%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks

TradingKey
·
Sep 01

Cboe data suggests bullish flow in Moderna with shares up 0.71%

TIPRANKS
·
Sep 01

Moderna Stock (MRNA) Was the Best Performer in August

TIPRANKS
·
Sep 01

New Listing Update | Betta Pharma Re-files for Hong Kong IPO, Leveraging a Quad-Driven Model to Build a Fully Integrated Biopharmaceutical Platform

Stock News
·
Aug 31

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

TIPRANKS
·
Aug 31

August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand

Deep News
·
Aug 30

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

TIPRANKS
·
Aug 29

Takeda receives FDA approval of NDA for Mimrylo

TIPRANKS
·
Aug 29

US Stocks Weekly: AI Refuel

Reuters
·
Aug 29

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

Dow Jones
·
Aug 29

BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial

Reuters
·
Aug 29

Top Calls On Wall Street: Nvidia, SpaceX, Moderna, TeraWulf , Amazon,Marvell, and More

Tiger Newspress
·
Aug 28

Moderna Stock Falls on $2B Notes Deal: Is the Cancer Rally Still Intact?

TradingKey
·
Aug 28

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

MT Newswires Live
·
Aug 28

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Reuters
·
Aug 28

Moderna Price Target Announced at $180.00/Share by Argus Research

Dow Jones
·
Aug 28

U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty

Reuters
·
Aug 28

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

Moderna Prices $2.6 Billion Convertible Notes due 2032

MT Newswires Live
·
Aug 28